Cargando…

Dynamic analysis of competition model between SARS-CoV-2 virus and immune system with vaccination

Detalles Bibliográficos
Autor principal:	Prihantini, Prihantini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498487/ http://dx.doi.org/10.1016/j.jns.2021.119911

Ejemplares similares

Competition of SARS-CoV-2 variants on the pandemic transmission dynamics
por: Chen, Jiaqi, et al.
Publicado: (2023)

Immunity, virus evolution, and effectiveness of SARS-CoV-2 vaccines
por: Belizário, J.E.
Publicado: (2021)

Infection- or vaccine mediated immunity reduces SARS-CoV-2 transmission, but increases competitiveness of Omicron in hamsters
por: Port, Julia R., et al.
Publicado: (2022)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

Mutation and SARS-CoV-2 strain competition under vaccination in a modified SIR model
por: Ahumada, M., et al.
Publicado: (2023)

Immune Response to SARS-CoV-2 Vaccines
por: Bellamkonda, Navya, et al.
Publicado: (2022)

SARS-CoV-2 virus: Vaccines in development
por: Huang, Qingrui, et al.
Publicado: (2021)

Correlated stochastic epidemic model for the dynamics of SARS-CoV-2 with vaccination
por: Khan, Tahir, et al.
Publicado: (2022)

Seeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines
por: Yue, Can, et al.
Publicado: (2023)

Selective sweeps in SARS-CoV-2 variant competition
por: Boyle, Laura, et al.
Publicado: (2022)

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
por: Liu, William J., et al.
Publicado: (2017)

Immune‐viral dynamics modeling for SARS‐CoV‐2 drug development
por: Cao, Youfang, et al.
Publicado: (2021)

Global dynamics of SARS-CoV-2/cancer model with immune responses
por: Elaiw, A.M., et al.
Publicado: (2021)

Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamsters
por: Port, Julia R., et al.
Publicado: (2023)

Virus replication and competition in a cell culture: Application to the SARS-CoV-2 variants
por: Ait Mahiout, L., et al.
Publicado: (2022)

Vaccine nationalism and the dynamics and control of SARS-CoV-2
por: Wagner, Caroline E., et al.
Publicado: (2021)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
por: Alluwaimi, Ahmed M., et al.
Publicado: (2020)

Dynamics of host immune responses to SARS-CoV-2
por: Taherkhani, Reza, et al.
Publicado: (2021)

Immunity to SARS‐CoV‐2 induced by infection or vaccination
por: Castro Dopico, Xaquin, et al.
Publicado: (2021)

Immune imprinting and SARS-CoV-2 vaccine design
por: Wheatley, Adam K., et al.
Publicado: (2021)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

SARS-CoV-2 Vaccines: The Mucosal Immunity Imperative
por: Adashi, Eli Y., et al.
Publicado: (2022)

SARS-CoV-2: virus dynamics and host response
por: Chen, Yu, et al.
Publicado: (2020)

Competitive Immunoassay of SARS-CoV-2 Using Pig Sera-Derived Anti-SARS-CoV-2 Antibodies
por: Bong, Ji-Hong, et al.
Publicado: (2021)

Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation
por: Lapointe, Christopher P., et al.
Publicado: (2021)

Animal models and vaccines for SARS-CoV infection
por: Roberts, Anjeanette, et al.
Publicado: (2008)

Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors
por: Pérez-Alós, Laura, et al.
Publicado: (2022)

Competitive sport after SARS-CoV-2 infection in children
por: Cafiero, Giulia, et al.
Publicado: (2021)

Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
por: Luo, Fan, et al.
Publicado: (2018)

Disparate temperature-dependent virus–host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium
por: V’kovski, Philip, et al.
Publicado: (2021)

Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
por: Wang, Qiao, et al.
Publicado: (2023)

Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years
por: Saad-Roy, Chadi M., et al.
Publicado: (2020)

Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2
por: Mufamadi, Maluta Steven, et al.
Publicado: (2023)

Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates
por: Schramm, Chaim A., et al.
Publicado: (2023)

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Ou, Xiuyuan, et al.
Publicado: (2020)

Dynamics of SARS-CoV-2 with waning immunity in the UK population
por: Crellen, Thomas, et al.
Publicado: (2021)

The time between vaccination and infection impacts immunity against SARS-CoV-2 variants
por: Bates, Timothy A., et al.
Publicado: (2023)

Limiting the priming dose of a SARS CoV-2 vaccine improves virus-specific immunity
por: Sanchez, Sarah, et al.
Publicado: (2021)

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2021)

SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura
por: Shah, Hridaya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0jethmbdmc89hmvqkfcgg2ktgr